Memorandum of Understanding Between the Food and Drug Administration and the Republic of Belarus

摘要

The Food and Drug Administration (FDA) is providing notice of a memorandum of understanding (MOU) between FDA and the Republic of Belarus. The purpose of the MOU is to exchange information on drugs and biological products and to facilitate the development of the Belarus health care sector by establishing in Belarus a streamlined registration procedure for U.S. drugs and biological products.